# Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso

> **NCT00261222** · PHASE2 · COMPLETED · sponsor: **Heidelberg University** · enrollment: 120 (—)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Amodiaquine

## Key facts

- **NCT ID:** NCT00261222
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 120 (—)
- **Last updated:** 2010-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261222, "Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00261222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*